Login / Signup

Preventing Cardiotoxicity in Personalized Breast Irradiation.

Edy IppolitoCarlo GrecoMaristella MarroccoCarla Germana RinaldiMichele FioreLuca Eolo TrodellaRolando Maria D'AngelilloSara Ramella
Published in: Cancers (2023)
The dosimetric advantage of DIBH is clear in all patients and DIBH should always be preferred.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • radiation therapy
  • prognostic factors